CoChat
Sign Up
Cited by 124Hematopoietic Stem Cell TransplantationBlood transfusion and managementNeutropenia and Cancer Infections

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte‐colony‐stimulating factor and dexamethasone

Dale, D.C., Liles, W.C., Llewellyn, C., Rodger, E., Price, T.H.·1998·Transfusion
DOI 10.1046/j.1537-2995.1998.38898375509.x
Open this paper in CoChat — free account

Abstract

BACKGROUND: The collection of adequate numbers of neutrophils (polymorphonuclear leukocytes, PMNs) from normal donors has long hampered the development of neutrophil transfusion therapy. The stimulation of donors with granulocyte‐colony‐stimulating factor (G‐ CSF) plus dexamethasone is a promising way of improving PMN collections. STUDY DESIGN AND METHODS:Sixteen normal subjects received G‐CSF (600 micrograms subcutaneously) and dexamethasone (8 mg by mouth) 12 hours before leukapheresis. Measurements included PMN morphology, immunophenotype analysis, chemiluminescence, bactericidal activity, in vivo kinetics, and adverse effects. RESULTS:A mean of 77.4 +/− 6.4 × 10(9) PMNs was collected with each leukapheresis; 14 percent were bands. PMNs had increased surface expression of CD11b, CD18, CD14, CD32, and CD64. Bactericidal capacity against Staphylococcus aureus was normal. Inducible respiratory burst was maintained, although the responses to some agonists were diminished. Returned leukapheresis cells labeled with 3H‐diisopropylfluorophosphate had a modestly decreased percentage of recovery and circulated with a prolonged half‐ life. Migration of these cells to skin chambers was approximately equal to that of the subjects' own blood PMNs. Adverse effects included transient bone pain, headache, hunger, and insomnia. CONCLUSIONS:Precollection treatment of leukapheresis donors with G‐CSF plus dexamethasone is an effective way to enhance the collection of PMNs with normal or near‐normal functional properties for PMN transfusion therapy.

Overview

Integrity signals

Registry

Crossref · 10.1046/j.1537-2995.1998.38898375509.x

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Research works printed but not linked: 7

  1. Leitman SF, 1995, Pair‐controlled study of granulocyte colony stimulating factor (G‐CSF) plus dexamethasone (Dexa) for granulocytapheresis donors (abstract), Transfusion, 35, 53s
  2. Itoh Y., 1991, In vivo effects of recombinant human granulocyte colony‐stimulating factor on normal PMN function and membrane effector molecule expression, Int J Hematol, 54, 463
  3. Balazovich KJ, 1991, Recombinant human G‐CSF and GM‐CSF prime human PMN for superoxide production through different signal transduction mechanisms, J Lab Clin Med, 118, 576
  4. Liles WC, 1994, Differential regulation of human neutrophil surface expression of CD14, CD11b, CD18, and l‐selectin following the administration of G‐CSF in vivo and in vitro, Clin Res, 42, 237a
  5. 10.1093/infdis/172.4.1061 · DOI
  6. Bowden R., 1997, Phase I/II study of granulocyte transfusions from G‐CSF‐stimulated unrelated donors for treatment infections in neutropenic blood and marrow transplant (BMT) patients (abstract), Blood, 90, 435a
  7. Price TH, 1997, Neutrophil collection from community apheresis donors after granulocyte colony‐stimulating factor and dexamethasone stimulation: feasibility and efficacy (abstract), Blood, 90, 137b

Cited by

Sorted by citations

See all 124

Related

Metadata

Authors
Dale, D. C., Liles, W. C., Llewellyn, C., Rodger, E., & Price, T. H.
Affiliations
University of Washington (US)
Corresponding author
Dale, D.C.
ORCID
Dale, D.C.
Venue
Transfusion
Publisher
Wiley
Published
1998-08
Volume
38
Issue
8
Pages
713-721
ISSN
  • 0041-1132 (ISSN-L)
  • 1537-2995
DOI
10.1046/j.1537-2995.1998.38898375509.x
OpenAlex
W2093230583
Cited by
124
References
41
Citations by year
2025: 2 · 2024: 2 · 2022: 3 · 2021: 4 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 11 · 2015: 8 · 2014: 4 · 2013: 5 · 2012: 5
FWCI
3.98
Type
journal article
Language
en
Open access
closed
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor, 1671 d)
Locations
  • Transfusion (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01hl053515-03)
  • National Heart, Lung, and Blood Institute (HL53515-02)
Topics
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Health Sciences › Medicine › Hematology › Blood transfusion and management
  • Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
Keywords
neutrophil transfusion, granulocyte colony-stimulating factor, dexamethasone, leukapheresis, donor mobilization, neutrophil kinetics, neutrophil migration, bactericidal activity, respiratory burst, CD11b, CD64, Staphylococcus aureus, adverse effects
MeSH terms
Adult, Cell Movement, Dexamethasone, Female, Humans, Leukapheresis, Leukocyte Count, Luminescent Measurements, Male, Middle Aged, Neutrophils, Staphylococcus aureus, Antigens, CD, Immunophenotyping, Granulocyte Colony-Stimulating Factor, Respiratory Burst, Leukocyte Transfusion, L-Selectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review